Skip to content
Trial Eligibility
Menu

Lung Cancer Clinical Trials near Ann Arbor, MI

111 studies for Lung Cancer are recruiting at 437 sites within 50 miles of Ann Arbor, Michigan, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Lung Cancer trials in the US or all trials near Ann Arbor.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Lung Cancer studies enrolling near Ann Arbor

Showing the 50 nearest of 111 studies.
  1. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    NCT05334069

    • Observational
    • Ages 40 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: Trinity Health Saint Joseph Mercy Hospital Ann Arbor (Ann Arbor, MI); Huron Gastroenterology PC (Ypsilanti, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    49 sites within 50 mi
  2. Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

    NCT03851445

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Trinity Health Saint Joseph Mercy Hospital Ann Arbor (Ann Arbor, MI); University of Michigan Rogel Cancer Center (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    42 sites within 50 mi
  3. Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

    NCT04267848

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Trinity Health Saint Joseph Mercy Hospital Ann Arbor (Ann Arbor, MI); Huron Gastroenterology PC (Ypsilanti, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    35 sites within 50 mi
  4. Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

    NCT05624996

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Trinity Health Saint Joseph Mercy Hospital Ann Arbor (Ann Arbor, MI); Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus (Ypsilanti, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    29 sites within 50 mi
  5. Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

    NCT03191149

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Trinity Health Saint Joseph Mercy Hospital Ann Arbor (Ann Arbor, MI); Huron Gastroenterology PC (Ypsilanti, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    27 sites within 50 mi
  6. Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

    NCT04181060

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Trinity Health Saint Joseph Mercy Hospital Ann Arbor (Ann Arbor, MI); Huron Gastroenterology PC (Ypsilanti, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    23 sites within 50 mi
  7. Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

    NCT06498635

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: University of Michigan Rogel Cancer Center (Ann Arbor, MI); Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus (Ypsilanti, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    23 sites within 50 mi
  8. Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

    NCT05642572

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Trinity Health Saint Joseph Mercy Hospital Ann Arbor (Ann Arbor, MI); Huron Gastroenterology PC (Ypsilanti, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    18 sites within 50 mi
  9. Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

    NCT06031688

    • Phase 2
    • Ages 18 Minutes and older
    • Sex: All

    Nearest sites: Trinity Health Saint Joseph Mercy Hospital Ann Arbor (Ann Arbor, MI); Huron Gastroenterology PC (Ypsilanti, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    12 sites within 50 mi
  10. A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

    NCT07293247

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Trinity Health Saint Joseph Mercy Hospital Ann Arbor (Ann Arbor, MI); Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus (Ypsilanti, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    9 sites within 50 mi
  11. Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

    NCT06116682

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Trinity Health Saint Joseph Mercy Hospital Ann Arbor (Ann Arbor, MI); Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus (Ypsilanti, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  12. Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

    NCT06881784

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Trinity Health Ann Arbor Hospital (Ann Arbor, MI); Henry Ford Health (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  13. Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

    NCT06767514

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Clinical Study Site (Ann Arbor, MI); Clinical Study Site (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  14. Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases

    NCT05588388

    • Phase 2
    • Ages Any age
    • Sex: All

    Nearest sites: University of Michigan (Ann Arbor, MI); V.A. Ann Arbor Healthcare System (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  15. A Phase 1/1b Study of IAM1363 in HER2 Cancers

    NCT06253871

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: University of Michigan (Ann Arbor, MI); Henry Ford Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  16. Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

    NCT06418204

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Trinity Health Saint Joseph Mercy Hospital Ann Arbor (Ann Arbor, MI); Trinity Health Saint Joseph Mercy Oakland Hospital (Pontiac, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  17. A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

    NCT06667076

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: University of Michigan Health System (Ann Arbor, MI); Trinity Health St Joseph Mercy Ann Arbor (Ypsilanti, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  18. Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

    NCT02984761

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest site: VA Ann Arbor Healthcare System, Ann Arbor, MI (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    NCT03452774

    • Observational
    • Ages Any age
    • Sex: All

    Nearest site: Massive Bio SYNERGY-AI site (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

    NCT04302025

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Michigan (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

    NCT04777994

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 252010 (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer

    NCT05467748

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: VA Ann Arbor Healthcare System, Ann Arbor, MI (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

    NCT05902988

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Michigan (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

    NCT05941507

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Michigan (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

    NCT06119581

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Michigan (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. Gilteritinib for the Treatment of ALK NSCLC

    NCT06225427

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Michigan Comprehensive Cancer Center (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. Repositioning Immunotherapy in VetArans With Lung Cancer

    NCT06275360

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: VA Ann Arbor Healthcare System, Ann Arbor, MI (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. A Registry for People With Lung Cancer

    NCT06424327

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Michigan (Data Collection Only) (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)

    NCT06598306

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Trinity Health Saint Joseph Mercy Ann Arbor (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

    NCT06805825

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Michigan Hospitals (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  31. A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

    NCT07020221

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Michigan (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  32. A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

    NCT07140016

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Michigan Health Systems (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  33. A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)

    NCT07221474

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: VA Ann Arbor Healthcare System ( Site 0019) (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  34. A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients

    NCT07291414

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Michigan Comprehensive Cancer Center (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  35. Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

    NCT07499674

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Michigan (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  36. Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

    NCT06769126

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus (Ypsilanti, MI); Trinity Health IHA Medical Group Hematology Oncology - Canton (Canton, MI)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    15 sites within 50 mi
  37. Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

    NCT06096844

    • Phase 3
    • Ages 70 years and older
    • Sex: All

    Nearest sites: Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus (Ypsilanti, MI); Trinity Health IHA Medical Group Hematology Oncology - Canton (Canton, MI)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  38. Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

    NCT06616584

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus (Ypsilanti, MI); Trinity Health IHA Medical Group Hematology Oncology - Canton (Canton, MI)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  39. Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)

    NCT07393555

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus (Ypsilanti, MI); Trinity Health IHA Medical Group Hematology Oncology - Canton (Canton, MI)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  40. Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

    NCT06422143

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Trinity Health Saint Joseph Mercy Hospital Ann Arbor ( Site 9552) (Ypsilanti, MI)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  41. The Vanguard Study: Testing a New Way to Screen for Cancer

    NCT06995898

    • Interventional
    • Ages 45 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: Henry Ford Medical Center - Plymouth (Plymouth, MI); Henry Ford Medical Center-Columbus (Novi, MI)

    Distance to nearest recruiting site
    ~15 mi (city-level)
    Recruiting sites
    13 sites within 50 mi
  42. Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

    NCT06357533

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Research Site (Farmington Hills, MI); Research Site (Dearborn, MI)

    Distance to nearest recruiting site
    ~24 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  43. A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

    NCT05208762

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Karmanos Cancer Institute (Farmington Hills, MI); Karmanos Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    ~24 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  44. Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

    NCT06463665

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Oakland Medical Group (Farmington Hills, MI); Michigan Hematology and Oncology Consultants (Dearborn, MI)

    Distance to nearest recruiting site
    ~24 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  45. Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

    NCT06500481

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Weisberg Cancer Treatment Center (Farmington Hills, MI); Wayne State University/Karmanos Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    ~24 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  46. A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

    NCT06793215

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Profound Research, LLC (Farmington Hills, MI)

    Distance to nearest recruiting site
    ~24 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  47. A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors

    NCT06956690

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Research Site (Farmington Hills, MI)

    Distance to nearest recruiting site
    ~24 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  48. A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

    NCT07085091

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: ALX Center 8 (Farmington Hills, MI)

    Distance to nearest recruiting site
    ~24 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  49. A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)

    NCT07541170

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Profound Research, LLC (Farmington Hills, MI)

    Distance to nearest recruiting site
    ~24 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  50. A Study of IBI363 in Subjects with Advanced Solid Malignancies

    NCT06281678

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Michigan Hematology & Oncology Consultants - MedOnc Dearborn (Dearborn, MI); Michigan Hematology & Oncology Consultants - MedOnc Troy (Troy, MI)

    Distance to nearest recruiting site
    ~29 mi (city-level)
    Recruiting sites
    2 sites within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Lung Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.